Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6439)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 27, 2021 (publication date) through Feb 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bellanti F, Vendemiale G. Coronavirus disease 2019 and non-alcoholic fatty liver disease. World J Hepatol 2021; 13(9): 969-978 [PMID: PMC8473503 DOI: 10.4254/wjh.v13.i9.969] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i9/969.htm |
| Number | Citing Articles |
| 1 |
Dafeng Liu, Yongli Zheng, Jun Kang, Dongmei Wang, Lang Bai, Yi Mao, Guifang Zha, Hong Tang, Renqing Zhang. Not Only High Number and Specific Comorbidities but Also Age Are Closely Related to Progression and Poor Prognosis in Patients With COVID-19. Frontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.736109
|
| 2 |
Andrew J. Krentz. Cardiovascular Endocrinology and Metabolism. 2023; : 39 doi: 10.1016/B978-0-323-99991-5.00010-3
|
| 3 |
Ka Shing Cheung, Lok Ka Lam, Rex Wan Hin Hui, Xianhua Mao, Ruiqi R Zhang, Kwok Hung Chan, Ivan FN Hung, Wai Kay Seto, Man-Fung Yuen. Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients. Clinical and Molecular Hepatology 2022; 28(3): 553 doi: 10.3350/cmh.2022.0082
|
| 4 |
Dhanvee Balaji, Ranjith Balakrishnan, Dhasarathdev Srinivasan, Rajasekaran Subbarayan, Rupendra Shrestha, Nityanand Srivastava, Ankush Chauhan. The Impact of SARS-CoV-2 on Liver Diseases and Potential Phytochemical Treatments. Infectious Microbes and Diseases 2024; 6(4): 177 doi: 10.1097/IM9.0000000000000161
|